NATURE OF BUSINESS (Details)									1 Months Ended	3 Months Ended						9 Months Ended
	Nov. 25, 2022	Apr. 20, 2022 shares	Nov. 11, 2021 $ / shares shares	Sep. 03, 2021 USD ($)	Jul. 09, 2021 USD ($)	Dec. 07, 2020 USD ($)	Jun. 30, 2020 shares	Jan. 19, 2017 USD ($) shares	Jul. 31, 2021 USD ($)	Mar. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Sep. 30, 2024 USD ($)	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Sep. 30, 2023 USD ($)	Mar. 31, 2025 USD ($) shares	Mar. 31, 2024 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Nov. 26, 2022 USD ($)	Nov. 15, 2021 shares	Nov. 04, 2021	Apr. 06, 2021	Feb. 04, 2021
NATURE OF BUSINESS (Details) [Line Items]
Stock Issued During Period, Shares, Acquisitions (in Shares) | shares							510,000,000	16,155,746,000
Proceeds from Sales of Business, Affiliate and Productive Assets								$ 100
Payments to Acquire Investments					$ 50,000
Number of Units in Real Estate Property				53
Number of Real Estate Properties				19
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Gross				$ 7,626,286.37
Payments to Acquire Real Estate				$ 7,000,000
Real Estate, Description of Terms				(i)$1,000,000 on execution of the Agreement, (ii) $2,000,000 within 60 days thereof and (iii) the remainder by April 10, 2022. The Agreement is subject to customary closing conditions, including, satisfactory due diligence.
Class of Warrant or Rights, Granted (in Shares) | shares			500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ / shares			$ 0.01
Warrants and Rights Outstanding, Term			24 months
Stock Issued During Period, Shares, New Issues (in Shares) | shares		500,000														13,823,282
Investment Owned, Balance, Shares (in Shares) | shares																					20,000,000
Agreement, Description	The Company A agrees that if the patent is sold or transferred, Men Hwei Tsai or Men Hwei, Tsai’s successor may receive a 25% gain on the transfer or sale of the interest. The Company agrees to give Men Hwei Tsai an additional 20 million AAGH shares. The Company allows Men Hwei, Tsai to use three years (from November 26, 2022 to November 25, 2025) find investors each with more than US$10 million investment. In case that no investor is found within three years, Men Hwei, Tsai agrees to return the patent to the Company, and both parties will continue to cooperate in accordance with the original contract on May 18, 2021. If Men Hwei Tsai finds an investor with an investment of at least US$10 million within three years, and the process for Men Hwei, Tsai and its investors to apply for a new drug may last for several years, then Men Hwei Tsai agrees that the Company will use the patented technology to develop dietary supplement that are helpful to Alzheimer’s disease. The Company will be responsible for marketing the dietary supplement. Men Hwei Tsai is entitled to commission equalling to 8% of sales price.
Other Commitment																				$ 34,978.48
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest										$ (158,377)	$ (193,702)	$ (146,967)	$ (228,507)	$ (249,345)	$ (156,980)	$ (499,046)	$ (634,833)
Net Cash Provided by (Used in) Operating Activities																(60,297)	(450,200)
Equity, Including Portion Attributable to Noncontrolling Interest										(5,709,609)	$ (5,576,377)	$ (5,389,271)	(4,718,783)	$ (4,623,268)	$ (4,525,038)	(5,709,609)	(4,718,783)	$ (5,311,599)	$ (4,370,836)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents										$ 36,880			$ 51,739			$ 36,880	$ 51,739	$ 54,943	$ 54,150
Corporate Joint Venture [Member]
NATURE OF BUSINESS (Details) [Line Items]
Payments to Acquire Interest in Joint Venture						$ 4,200,000
Co-venturer [Member]
NATURE OF BUSINESS (Details) [Line Items]
Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease)									$ 100,000
Gof Biotechnologies, Inc. [Member]
NATURE OF BUSINESS (Details) [Line Items]
Subsidiary, Ownership Percentage, Parent																					75.00%
Investment Owned, Balance, Shares (in Shares) | shares																					60,000,000
Subsidiary, Ownership Percentage, Noncontrolling Owner																					25.00%
Purecell Group [Member]
NATURE OF BUSINESS (Details) [Line Items]
Equity Method Investment, Ownership Percentage							51.00%			51.00%						51.00%							51.00%
JV Company [Member]
NATURE OF BUSINESS (Details) [Line Items]
Equity Method Investment, Ownership Percentage						60.00%
Brilliant Healthcare Limited [Member]
NATURE OF BUSINESS (Details) [Line Items]
Equity Method Investment, Ownership Percentage						40.00%
Nutrature Health LLC [Member]
NATURE OF BUSINESS (Details) [Line Items]
Equity Method Investment, Ownership Percentage										100.00%						100.00%						100.00%
Gof Biotechnologies, Inc. [Member]
NATURE OF BUSINESS (Details) [Line Items]
Equity Method Investment, Ownership Percentage																					100.00%
International Institute of Great Health, Inc. (IIGH) [Member]
NATURE OF BUSINESS (Details) [Line Items]
Equity Method Investment, Ownership Percentage																								100.00%
Common Stock [Member] | Co-venturer [Member]
NATURE OF BUSINESS (Details) [Line Items]
Payments to Acquire Interest in Joint Venture						$ 15,000,000
Cash Distribution [Member] | Co-venturer [Member]
NATURE OF BUSINESS (Details) [Line Items]
Payments to Acquire Interest in Joint Venture						$ 3,000,000